Stem cell therapy in heart diseases: A review of selected new perspectives, practical considerations and clinical applications

Current Cardiology Reviews

Volumn 7, Issue 3, 2011, Pages 201-212

  Abdelwahid, Eltyeb ^a   Siminiak, Tomasz ^b   Guarita Souza, Luiz César ^c   de Carvalho, Katherine Athayde Teixeira ^d   Gallo, Pasquale ^e,f   Shim, Winston ^g   Condorelli, Gianluigi ^e,f,h  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

^c PONTIFICAL CATHOLIC UNIVERSITY OF PARANÁ   (Brazil)

^d INSTITUTO DE PESQUISA PELÉ PEQUENO PRÍNCIPE   (Brazil)

^e San Raffaele Open University of Rome   (Italy)

^f IRCCS MULTIMEDICA   (Italy)

^g DEPARTMENT OF CARDIOLOGY   (Singapore)

^h UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

Heart; Stem cells; Therapy; Transplantation

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1;

ANGIOGENESIS; CARCINOGENICITY; CD8+ T LYMPHOCYTE; CELL ADHESION; CELL DENSITY; CELL DIFFERENTIATION; CELL NUCLEUS TRANSPLANTATION; CORONARY ARTERY BYPASS SURGERY; ECHOCARDIOGRAPHY; EMBRYONIC STEM CELL; ENDOTHELIUM CELL; FIBROBLAST; FLOW CYTOMETRY; FOLLOW UP; HEART DISEASE; HEART FUNCTION; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE BIOPSY; HEART SURGERY; HEART VENTRICLE REMODELING; HEART VENTRICLE TACHYCARDIA; HEMATOPOIETIC STEM CELL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTOLOGY; HISTOPATHOLOGY; HUMAN; IMMUNOLOGICAL TOLERANCE; IN VITRO STUDY; INFLAMMATION; ISCHEMIC HEART DISEASE; MESENCHYMAL STEM CELL TRANSPLANTATION; MORTALITY; MULTICENTER STUDY (TOPIC); MYOBLAST; NONHUMAN; PHARMACOLOGIC STRESS TESTING; PHASE 1 CLINICAL TRIAL (TOPIC); POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REVIEW; SKELETAL MUSCLE; SOMATIC CELL; STEM CELL TRANSPLANTATION; TERATOMA; VASCULARIZATION; VASTUS LATERALIS MUSCLE;

ANIMALS; BONE MARROW TRANSPLANTATION; EMBRYONIC STEM CELLS; HEART DISEASES; HUMANS; MESENCHYMAL STEM CELL TRANSPLANTATION; MYOBLASTS, CARDIAC; MYOCARDIAL INFARCTION; MYOCYTES, CARDIAC; STEM CELL TRANSPLANTATION;

EID: 82055197210     PISSN: 1573403X     EISSN: 18756557     Source Type: Journal    
DOI: 10.2174/157340311798220502     Document Type: Review

References (90)

1. Reubinoff BE, Itsykson P, Turetsky T, et al. Neural progenitors from human embryonic stem cells. Nat Biotechnol 2001; 19: 1134-1140.
2. Assady S, Maor G, Amit M, Itskovitz-Eldor J, Skorecki KL, Tzukerman M. Insulin production by human embryonic stem cells. Diabetes 2001; 50: 1691-1617.
3. Beyer EC, Paul DL, Goodenough DA. Connexin43: a protein from rat heart homologous to a gap junction protein from liver. J Cell Biol 1987; 105: 2621-2629.
4. Levenberg S, Golub JS, Amit M, Itskovitz-Eldor J, Langer R. Endothelial cells derived from human embryonic stem cells. Proc Natl Acad Sci USA 2002; 99: 4391-4396.
5. Kehat I, Khimovich L, Caspi O, et al. Electromechanical integration of cardiomyocytes derived from human embryonic stem cells. Nat Biotechnol 2004; 22: 1282-1289.
6. Mummery C, Ward D, van den Brink CE, et al. Cardiomyocyte differentiation of mouse and human embryonic stem cells. J Anat 2002; 200: 233-242.
7. Assmus B, Honold J, Schachinger V, Britten MB, Fischer-Rasokat U, Lehmann R, Teupe C, Pistorius K, Martin H, Abolmaali ND, Tonn T, Dimmeler S, Zeiher AM. Transcoronary transplantation of progenitor cells after myocardial infarction. N Engl J Med 2006; 355: 1222-1232.
8. Briguori C, Reimers B, Sarais C, et al. Direct intramyocardial percutaneous delivery of autologous bone marrow in patients with refractory myocardial angina. Am Heart J 2006; 151: 674-680.
9. Condorelli G, Borello U, De Angelis L, Latronico M, Sirabella D, Coletta M, Galli R, Balconi G, Follenzi A, Frati G, Cusella De Angelis MG, Gioglio L, et al. Cardiomyocytes induce endothelial cells to trans-differentiate into cardiac muscle: implications for myocardium regeneration. Proc Natl Acad Sci USA 2001; 98: 10733-10738.
10. Kehat I, Kenyagin-Karsenti D, Snir M, et al. Human embryonic stem cells can differentiate into myocytes with structural and functional properties of cardiomyocytes. J Clin Invest 2001; 108: 407-414.
11. Caspi O, Gepstein L. Potential applications of human embryonic stem cell-derived cardiomyocytes. Ann N Y Acad Sci 2004; 1015: 285-298.
12. Menasche P. Embryonic stem cells pace the heart. Nat Biotechnol 2004; 22: 1237-1238.
13. Odorico JS, Kaufman DS, Thomson JA. Multilineage differentiation from human embryonic stem cell lines. Stem Cells 2001; 19: 193-204.
14. Carpenter MK, Rosler ES, Fisk GJ, et al. Properties of four human embryonic stem cell lines maintained in a feeder-free culture system. Dev Dyn 2004; 229: 243-258.
15. Rosler ES, Fisk GJ, Ares X, et al. Long-term culture of human embryonic stem cells in feeder-free conditions. Dev Dyn 2004; 229: 259-274.
16. Abeyta MJ, Clark AT, Rodriguez RT, Bodnar MS, Pera RA, Firpo MT. Unique gene expression signatures of independently-derived human embryonic stem cell lines. Hum Mol Genet 2004; 13: 601-608.
17. Richards M, Fong CY, Chan WK, Wong PC, Bongso A. Human feeders support prolonged undifferentiated growth of human inner cell masses and embryonic stem cells. Nat Biotechnol 2002; 20: 933-936.
18. Pekkanen-Mattila M, Kerkela E, Tanskanen JM, et al. Substantial variation in the cardiac differentiation of human embryonic stem cell lines derived and propagated under the same conditions--a comparison of multiple cell lines. Ann Med 2009; 41: 360-370.
19. Stojkovic M, Lako M, Strachan T, Murdoch A. Derivation, growth and applications of human embryonic stem cells. Reproduction 2004; 128: 259-267.
20. Heng BC, Haider HK, Sim EK, Cao T, Tong GQ, Ng SC. Comments about possible use of human embryonic stem cell-derived cardiomyocytes to direct autologous adult stem cells into the cardiomyogenic lineage. Acta Cardiol 2005; 60: 7-12.
21. Heng BC, Cao T, Haider HK, Wang DZ, Sim EK, Ng SC. An overview and synopsis of techniques for directing stem cell differentiation in vitro. Cell Tissue Res 2004; 315: 291-303.
22. Heng BC, Cao T, Tong GQ, Ng SC. Potential utility of cellpermeable transcription factors to direct stem cell differentiation. Stem Cells Dev 2004; 13: 460-462.
23. Heng BC, Haider HK, Sim EK, Cao T, Ng SC. Strategies for directing the differentiation of stem cells into the cardiomyogenic lineage in vitro. Cardiovasc Res 2004; 62: 34-42.
24. Stevens KR, Kreutziger KL, Dupras SK, et al. Physiological function and transplantation of scaffold-free and vascularized human cardiac muscle tissue. Proc Natl Acad Sci USA 2009; 106: 16568-16573.
25. Martin MJ, Muotri A, Gage F, Varki A. Human embryonic stem cells express an immunogenic nonhuman sialic acid. Nat Med 2005; 11: 228-232.
26. Ellerstrom C, Strehl R, Moya K, et al. Derivation of a xeno-free human embryonic stem cell line. Stem Cells 2006; 24: 2170-2176.
27. Rajala K, Hakala H, Panula S, et al. Testing of nine different xenofree culture media for human embryonic stem cell cultures. Hum Reprod 2007; 22: 1231-1238.
28. Amit M, Margulets V, Segev H, et al. Human feeder layers for human embryonic stem cells. Biol Reprod 2003; 68: 2150-6.
29. Unger C, Skottman H, Blomberg P, Dilber MS, Hovatta O. Good manufacturing practice and clinical-grade human embryonic stem cell lines. Hum Mol Genet 2008; 17: R48-53.
30. Pekkanen-Mattila M, Chapman H, Kerkela E, et al. Human embryonic stem cell-derived cardiomyocytes: demonstration of a portion of cardiac cells with fairly mature electrical phenotype. Exp Biol Med (Maywood) 2010; 235: 522-530.
31. Drukker M, Katz G, Urbach A, et al. Characterization of the expression of MHC proteins in human embryonic stem cells. Proc Natl Acad Sci USA 2002; 99: 9864-9869.
32. Robertson NJ, Brook FA, Gardner RL, Cobbold SP, Waldmann H, Fairchild PJ. Embryonic stem cell-derived tissues are immunogenic but their inherent immune privilege promotes the induction of tolerance. Proc Natl Acad Sci USA 2007; 104: 20920-20925.
33. Lanzendorf SE, Boyd CA, Wright DL, Muasher S, Oehninger S, Hodgen GD. Use of human gametes obtained from anonymous donors for the production of human embryonic stem cell lines. Fertil Steril 2001; 76: 132-137.
34. Hwang WS, Ryu YJ, Park JH, et al. Evidence of a pluripotent human embryonic stem cell line derived from a cloned blastocyst. Science 2004; 303: 1669-1674.
35. Armstrong L, Lako M, Dean W, Stojkovic M. Epigenetic modification is central to genome reprogramming in somatic cell nuclear transfer. Stem Cells 2006; 24: 805-814.
36. Rodriguez-Piza I, Richaud-Patin Y, Vassena R, et al. Reprogramming of human fibroblasts to induced pluripotent stem cells under xeno-free conditions. Stem Cells 2010; 28: 36-44.
37. Takahashi K, Tanabe K, Ohnuki M, et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007; 131: 861-872.
38. Ieda M, Fu JD, Delgado-Olguin P, et al. Direct reprogramming of fibroblasts into functional cardiomyocytes by defined factors. Cell 2010; 142: 375-386.
39. Thomson JA, Itskovitz-Eldor J, Shapiro SS, et al. Embryonic stem cell lines derived from human blastocysts. Science 1998; 282: 1145-1147.
40. Thomson JA, Kalishman J, Golos TG, et al. Isolation of a primate embryonic stem cell line. Proc Natl Acad Sci USA 1995; 92: 7844-7848.
41. Doss MX, Koehler CI, Gissel C, Hescheler J, Sachinidis A. Embryonic stem cells: a promising tool for cell replacement therapy. J Cell Mol Med 2004; 8: 465-473.
42. Mitjavila-Garcia MT, Simonin C, Peschanski M. Embryonic stem cells: meeting the needs for cell therapy. Adv Drug Deliv Rev 2005; 57: 1935-1943.
43. Bjorklund LM, Sanchez-Pernaute R, Chung S, et al. Embryonic stem cells develop into functional dopaminergic neurons after transplantation in a Parkinson rat model. Proc Natl Acad Sci USA 2002; 99: 2344-2349.
44. Asano T, Ageyama N, Takeuchi K, et al. Engraftment and tumor formation after allogeneic in utero transplantation of primate embryonic stem cells. Transplantation 2003; 76: 1061-1067.
45. Hattori F, Chen H, Yamashita H, et al. Nongenetic method for purifying stem cell-derived cardiomyocytes. Nat Methods 2010; 7: 61-66.
46. Van Hoof D, Dormeyer W, Braam SR, et al. Identification of cell surface proteins for antibody-based selection of human embryonic stem cell-derived cardiomyocytes. J Proteome Res 2010; 9: 1610-1618.
47. Hattori F, Fukuda K. Strategies for ensuring that regenerative cardiomyocytes function properly and in cooperation with the host myocardium. Exp Mol Med 2010; 42: 155-165.
48. Ghostine S, Carrion C, Souza LC, et al. Long-term efficacy of myoblast transplantation on regional structure and function after myocardial infarction. Circulation 2002; 106: I131-I136.
49. Murry CE, Wiseman RW, Schwartz SM, Hauschka SD. Skeletal myoblast transplantation for repair of myocardial necrosis. J Clin Invest 1996; 98: 2512-2523.
50. Scorsin M, Hagege A, Vilquin JT, et al. Comparison of the effects of fetal cardiomyocyte and skeletal myoblast transplantation on postinfarction left ventricular function. J Thorac Cardiovasc Surg 2000; 119: 1169-1175.
51. Taylor DA, Atkins BZ, Hungspreugs P, et al. Regenerating functional myocardium: improved performance after skeletal myoblast transplantation. Nat Med 1998; 4: 929-933.
52. Dorfman J, Duong M, Zibaitis A, et al. Myocardial tissue engineering with autologous myoblast implantation. J Thorac Cardiovasc Surg 1998; 116: 744-751.
53. Menasche P, Hagege AA, Vilquin JT, et al. Autologous skeletal myoblast transplantation for severe postinfarction left ventricular dysfunction. J Am Coll Cardiol 2003; 41: 1078-1083.
54. Chachques JC, Herreros J, Trainini J, et al. Autologous human serum for cell culture avoids the implantation of cardioverterdefibrillators in cellular cardiomyoplasty. Int J Cardiol 2004; 95 Suppl 1: S29-S33.
55. Verfaillie CM. Adult stem cells: assessing the case for pluripotency. Trends Cell Biol 2002; 12: 502-50
56. Guarita-Souza LC, Carvalho KA, Rebelatto C, et al. Cell transplantation: differential effects of myoblasts and mesenchymal stem cells. Int J Cardiol 2006; 111: 423-9.
57. Souza LC, Carvalho KA, Rebelatto C, et al. Combined transplantation of skeletal myoblasts and mesenchymal cells (cocultivation) in ventricular dysfunction after myocardial infarction. Arq Bras Cardiol 2004; 83: 294-9; 288-293.
58. Menasche P, Hagege AA, Vilquin JT, et al. Autologous skeletal myoblast transplantation for severe postinfarction left ventricular dysfunction. J Am Coll Cardiol 2003; 41: 1078-1083.
59. Guarita-Souza LC, Carvalho KA, Woitowicz V, et al. Simultaneous autologous transplantation of cocultured mesenchymal stem cells and skeletal myoblasts improves ventricular function in a murine model of Chagas disease. Circulation 2006; 114: I120-I124.
60. Carvalho KA, Guarita-Souza LC, Rebelatto CL, et al. Could the coculture of skeletal myoblasts and mesenchymal stem cells be a solution for postinfarction myocardial scar? Transplant Proc 2004; 36: 991-992.
61. Perin EC, Dohmann HF, Borojevic R, et al. Transendocardial, autologous bone marrow cell transplantation for severe, chronic ischemic heart failure. Circulation 2003; 107: 2294-2302.
62. Orlic D, Kajstura J, Chimenti S, Bodine DM, Leri A, Anversa P. Bone marrow stem cells regenerate infarcted myocardium. Pediatr Transplant 2003; 7 Suppl 3: 86-88.
63. Wollert KC, Meyer GP, Lotz J, et al. Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial. Lancet 2004; 364: 141-148.
64. Strauer BE, Brehm M, Zeus T, et al. Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans. Circulation 2002; 106: 1913-1918.
65. Silva GV, Litovsky S, Assad JA, et al. Mesenchymal stem cells differentiate into an endothelial phenotype, enhance vascular density, and improve heart function in a canine chronic ischemia model. Circulation 2005; 111: 150-156.
66. Friedenstein AJ, Petrakova KV, Kurolesova AI, Frolova GP. Heterotopic of bone marrow. Analysis of precursor cells for osteogenic and hematopoietic tissues. Transplantation 1968; 6: 230-247.
67. Guarita-Souza LC, Carvalho KA, Simeone BR, Franscisco JC, Miyague N, Olandoski M. Functional outcome of bone marrow stem cells: mononuclear versus mesenchymal stem cells after cellular therapy in myocardial scar in Wistar rats. Transplant Proc 2006; 38: 1953-1954.
68. Guarita-Souza LC, Carvalho KA, Rebelatto C, et al. Comparison of mononuclear and mesenchymal stem cell transplantation in myocardium infarction. Brazilian Journal of Cardiovascular Surgery 2005; 20: 270-278.
69. Siminiak T, Kurpisz M. Myocardial replacement therapy. Circulation 2003; 108: 1167-1171.
70. Gnecchi M, Zhang Z, Ni A, Dzau VJ. Paracrine mechanisms in adult stem cell signaling and therapy. Circ Res 2008; 103: 1204-1219.
71. Wang J-S., Shum-Tim D., Chedrawy E. Marrow stromal cells for cellular cardiomyoplasty: the importance of microenvironment for milieu dependent differentiation. Circulation 2000; 102: II-683.
72. Bel A, Messas E, Agbulut O, et al. Transplantation of autologous fresh bone marrow into infarcted myocardium: a word of caution. Circulation 2003; 108 Suppl 1: II247-I252.
73. Menasche P, Hagege AA, Scorsin M, et al. Myoblast transplantation for heart failure. Lancet 2001; 357: 279-220.
74. Siminiak T, Kalawski R, Kurpisz M. Myoblast transplantation in the treatment of postinfarction myocardial contractility impairment. Kardiol Pol 2002; 56: 131-7.
75. Siminiak T, Kalawski R, Fiszer D, et al. Transplantation of autologous skeletal myoblasts in the treatment of patients with postinfarction heart failure. Circulation 2002; 106: II-636.
76. Dib N., McCarthy P., Campbell A. Safety and feasibility of autologous myoblast transplantation in patients undergoing coronary artery bypass grafting: results from the United States experience. J Am Coll Cardiol 2003; 41 suppl.
77. Herreros J, Prosper F, Perez A, et al. Autologous intramyocardial injection of cultured skeletal muscle-derived stem cells in patients with non-acute myocardial infarction. Eur Heart J 2003; 24: 2012-2020.
78. Menasche P, Alfieri O, Janssens S, et al. The Myoblast Autologous Grafting in Ischemic Cardiomyopathy (MAGIC) trial: first randomized placebo-controlled study of myoblast transplantation. Circulation 2008; 117: 1189-1200.
79. Smits PC, van Geuns RJ, Poldermans D, et al. Catheter-based intramyocardial injection of autologous skeletal myoblasts as aprimary treatment of ischemic heart failure: clinical experience with six-month follow-up. J Am Coll Cardiol 2003; 42: 2063-2069.
80. Siminiak T, Fiszer D, Jerzykowska O, Grygielska B, Kalmucki P, Kurpisz M. Percutaneous autologous myoblast transplantation in the treatment of post-infarction myocardial contractility impairment- report on two cases. Kardiol Pol 2003; 59: 492-501.
81. Siminiak T, Fiszer D, Jerzykowska O, et al. Percutaneous transcoronary- venous transplantation of autologous skeletal myoblasts in the treatment of post-infarction myocardial contractility impairment: the POZNAN trial. Eur Heart J 2005; 26: 1188-1195.
82. Sherman W, Martens TP, Viles-Gonzalez JF, Siminiak T. Catheterbased delivery of cells to the heart. Nat Clin Pract Cardiovasc Med 2006; 3 Suppl 1: S57-S64.
83. Siminiak T, Kalmucki P, Kurpisz M. Autologous skeletal myoblasts for myocardial regeneration. J Interv Cardiol 2004; 17: 357-365.
84. Thompson CA, Nasseri BA, Makower J, et al. Percutaneous transvenous cellular cardiomyoplasty. A novel nonsurgical approach for myocardial cell transplantation. J Am Coll Cardiol 2003; 41: 1964-1971.
85. Thompson CA, Oesterle SN. Biointerventional cardiology: the future interface of interventional cardiovascular medicine and bioengineering. Vasc Med 2002; 7: 135-140.
86. Smits PC, Nienaber C, Colombo A, et al. Myocardial repair by percutaneous cell transplantation of autologous skeletal myoblast as a stand alone procedure in post myocardial infarction chronic heart failure patients. EuroIntervention 2006; 1: 417-424.
87. Pagani FD, DerSimonian H, Zawadzka A, et al. Autologous skeletal myoblasts transplanted to ischemia-damaged myocardium in humans. Histological analysis of cell survival and differentiation. J Am Coll Cardiol 2003; 41: 879-888.
88. Taylor DA, Atkins BZ, Hungspreugs P, et al. Regenerating functional myocardium: improved performance after skeletal myoblast transplantation. Nat Med 1998; 4: 929-933.
89. Hagege AA, Vilquin JT, Bruneval P, Menasche P. Regeneration of the myocardium: a new role in the treatment of ischemic heart disease? Hypertension 2001; 38: 1413-1415.
90. Menasche P, Hagege AA, Scorsin M, et al. Myoblast transplantation for heart failure. Lancet 2001; 357: 279-280.